Cart
sales@molnova.com
mulberroside B
CAS No. 75872-12-7
mulberroside B( —— )
Catalog No. M19082 CAS No. 75872-12-7
Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 284 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namemulberroside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
DescriptionAntitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75872-12-7
-
Formula Weight356.28
-
Molecular FormulaC15H16O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](OC2=C(O)C(O3)=C(C=C2O)C=CC3=O)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MAPK13-IN-1
MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
-
SKF-86002
SKF-86002 is a potent inhibitor of p38 MAPK with IC50 of 0.5-1 uM, inhibits LPS-induced IL-1 and TNF-α production in human monocyte with IC50 of 1 uM.
-
HPK1-IN-4
HPK1-IN-4 is an HPK1 (MAPK41) inhibitor with an IC 50 of 0.061 nM. HPK1-IN-4 is often used as a preclinical immunotherapy tool compound.
